Human Genome Sciences Will Sponsor Conference Call To Review Recent Activities

Apr 04, 2001, 01:00 ET from Human Genome Sciences, Inc.

    ROCKVILLE, Md., April 4 /PRNewswire/ -- Human Genome Sciences, Inc.
 (Nasdaq:   HGSI) announced today that it will sponsor a conference call for
 investors to review recent corporate developments.
     The conference call will be held on Thursday, April 5, 2001, at 1:00 p.m.
 Eastern, and will be hosted by William A. Haseltine, Ph.D., Chairman and Chief
 Executive Officer of Human Genome Sciences, Inc.
     Investors may listen to the call by dialing 913-981-5533 or 800-289-0544,
 meeting number 425429, five to ten minutes before the start of the call.  A
 replay of the call will be available until 5 pm Eastern on April 10, 2001, by
 dialing 719-457-0820, meeting number 425429.
     Human Genome Sciences is a company with the mission to treat and cure
 disease by bringing new gene-based drugs to patients.
     HGS and Human Genome Sciences are registered trademarks of Human Genome
 Sciences, Inc.  For additional information on Human Genome Sciences, Inc.,
 visit the company's web site at http://www.hgsi.com .  Copies of HGS press
 releases are also available by fax 24 hours a day at no charge by calling
 800-758-5804, ext. 121115.
 
 

SOURCE Human Genome Sciences, Inc.
    ROCKVILLE, Md., April 4 /PRNewswire/ -- Human Genome Sciences, Inc.
 (Nasdaq:   HGSI) announced today that it will sponsor a conference call for
 investors to review recent corporate developments.
     The conference call will be held on Thursday, April 5, 2001, at 1:00 p.m.
 Eastern, and will be hosted by William A. Haseltine, Ph.D., Chairman and Chief
 Executive Officer of Human Genome Sciences, Inc.
     Investors may listen to the call by dialing 913-981-5533 or 800-289-0544,
 meeting number 425429, five to ten minutes before the start of the call.  A
 replay of the call will be available until 5 pm Eastern on April 10, 2001, by
 dialing 719-457-0820, meeting number 425429.
     Human Genome Sciences is a company with the mission to treat and cure
 disease by bringing new gene-based drugs to patients.
     HGS and Human Genome Sciences are registered trademarks of Human Genome
 Sciences, Inc.  For additional information on Human Genome Sciences, Inc.,
 visit the company's web site at http://www.hgsi.com .  Copies of HGS press
 releases are also available by fax 24 hours a day at no charge by calling
 800-758-5804, ext. 121115.
 
 SOURCE  Human Genome Sciences, Inc.